UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056422
Receipt number R000064469
Scientific Title Efficacy and safety analysis of pre-co-seasonal sublingual immunotherapy for Japanese cedar pollinosis: A multicenter randomized parallel-group comparative trial
Date of disclosure of the study information 2025/01/01
Last modified on 2025/06/11 09:09:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety analysis of pre-co-seasonal sublingual immunotherapy for Japanese cedar pollinosis

Acronym

PC-SLIT for JCP

Scientific Title

Efficacy and safety analysis of pre-co-seasonal sublingual immunotherapy for Japanese cedar pollinosis: A multicenter randomized parallel-group comparative trial

Scientific Title:Acronym

PC-SLIT for JCP

Region

Japan


Condition

Condition

Japanese cedar pollinosis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Currently, sublingual immunotherapy for Japanese cedar pollinosis, which is a curative treatment, is administered throughout the year. However, in other countries, pre-co-seasonal sublingual immunotherapy (PC-SLIT), which is administered from three months before the pollen season to during the pollen season, is mainstream, and its efficacy and safety have been demonstrated. This study aims to evaluate the efficacy and safety of PC-SLIT for Japanese cedar pollonosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total nasal symptom score over one Week during the peak of the pollen season

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Pre-co-seasonal sublingual immunotherapy

Interventions/Control_2

Year-round sublingual immunotherapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with Japanese cedar pollinosis who started sublingual immunotherapy with cedar sublingual tablets (Cedarcure) during the year 2024
2.Patients who are maintained on sublingual immunotherapy with Cedarcure 5,000 JAU tablets
3.Patients with a serum cedar-specific IgE class of 2 or higher
4.Patients who can obtain written consent from themselves to participate in the study of their own free will
5.Patients who are 5 years or older at the time of consent
6.Gender: Not specified
7.Outpatient

Key exclusion criteria

1.Women who are pregnant or may become pregnant
2.Patients diagnosed with cancer
3.Patients taking oral steroids (more than 10 mg/day of prednisolone for more than two consecutive weeks)
4.Patients receiving omalizumab, dupilumab, mepolizumab, benralizumab, or tezepelumab
5.Patients with severe asthma
6.Patients with a history of anaphylaxis
7.Patients with a history of hypersensitivity to adrenaline
8.Patients judged to have complications or infections that affect the heart, liver, kidneys, blood diseases, or other conditions that could impact the conduct of the study
9.Patients deemed unsuitable for study participation by the investigator

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Mitsuhiro
Middle name
Last name Okano

Organization

International University of Health and Welfare

Division name

Otorhinolaryngology, Head and Neck Surgery

Zip code

2868686

Address

852 Hatakeda, Narita

TEL

0476-35-5600

Email

mokano@iuhw.ac.jp


Public contact

Name of contact person

1st name Maiko
Middle name
Last name Maruyama

Organization

International University of Health and Welfare

Division name

Otorhinolaryngology, Head and Neck Surgery

Zip code

2868686

Address

852 Hatakeda, Narita

TEL

0476-35-5600

Homepage URL


Email

maruyama-maiko-kj@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare Ethics Review Board for Clinical Research

Address

852 Hatakeda, Narita

Tel

0476-35-5600

Email

rinri_md@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

89

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 10 Month 10 Day

Date of IRB

2024 Year 10 Month 10 Day

Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2026 Year 07 Month 31 Day

Date of closure to data entry

2026 Year 07 Month 31 Day

Date trial data considered complete

2026 Year 07 Month 31 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 12 Month 10 Day

Last modified on

2025 Year 06 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064469